Elutia Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
ELUT Nasdaq 2836 elutia.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Elutia Inc.

Elutia Receives $8 Million Payment from Boston Scientific; Company Now Fully Funded into 2029 - Oct 1st, 2026 2:45 pm
Elutia to Present at the H.C. Wainwright 28th Annual Global Investment Conference on September 15th - Sep 10th, 2026 2:05 pm
Elutia to Participate in the Lake Street Capital Markets 10th Annual Big Ideas Growth Conference & the H.C. Wainwright 28th Annual Global Investment Conference - Sep 2nd, 2026 2:05 pm
Elutia (ELUT) Q2 2026 Earnings Call Transcript - Aug 20th, 2026 2:58 pm
Cellution Biologics Completes Acquisition of SimpliDerm® from Elutia Inc. - Aug 18th, 2026 9:19 am
Elutia Completes SimpliDerm® Sale on Schedule, Adds $8 Million in Cash to Fund NXT-41x Through Full Commercial Launch - Aug 18th, 2026 6:00 am
Elutia Inc. Q2 2026 Earnings Call Summary - Aug 14th, 2026 6:30 am
Elutia Inc (ELUT) (Q2 2026) Earnings Call Highlights: Strategic Pivot to NXT41X Drives Strong ... - Aug 13th, 2026 11:01 pm
Elutia Secures Up to $26 Million to Fund NXT-41x Through Commercial Launch; Reports Second Quarter 2026 Results - Aug 13th, 2026 2:10 pm
Elutia Secures $15 Million Loan Financing from Avenue Capital Group to Fund NXT-41x Launch in $1.5 Billion Plastic and Reconstructive Surgery Market - Aug 13th, 2026 2:05 pm
Elutia to Report Second Quarter 2026 Financial Results on Thursday, August 13, 2026 - Jul 31st, 2026 6:00 am
Cellution Biologics Inc. Signs Definitive Agreement to Acquire SimpliDerm® Human Hydrated Acellular Dermal Matrix Business from Elutia Inc., Expanding its Allograft Portfolio - Jul 16th, 2026 2:21 pm
Elutia Signs Definitive Agreement to Sell SimpliDerm® in Transaction Valued at up to $11 Million, Strengthening Balance Sheet Ahead of NXT-41x Launch - Jul 16th, 2026 2:05 pm
Elutia to Present at Planet MicroCap Showcase 2026 on June 17th - Jun 11th, 2026 2:05 pm
Elutia (ELUT) Q1 2026 Earnings Transcript - May 15th, 2026 6:58 am
Elutia Inc (ELUT) Q1 2026 Earnings Call Highlights: Strategic Advances Amid Revenue Shifts - May 14th, 2026 11:01 pm
Elutia Reports First Quarter 2026 Results and Highlights NXT-41x Progress Toward $1.5 Billion U.S. Plastic and Reconstructive Surgery Market - May 14th, 2026 2:05 pm